The global Craniomaxillofacial devices market size was valued at USD 2.45 billion in 2018 and is expected to witness a CAGR of 6.0% during the forecast period. Increasing demand for minimally invasive surgeries is expected to drive the demand for Craniomaxillofacial (CMF) devices. Rising incidence of road accidents due to urbanization and industrialization coupled with rising demand for effective reconstructive surgeries are expected to enable growth.
Rising cases of facial fractures is expected to result mainly from combat sports (approximately 80%). Nose and teeth are the most injured areas and require more attention pertaining to prevention measures. Out of all the combat sports, kickboxing is the most injurious sport and it has resulted in the highest number of maxillofacial trauma. This drives the demand for craniomaxillofacial implants.
In addition, increasing awareness amongst consumers is one of the key contributing factors for the market growth. For instance, organizations such as the American Society of Craniofacial Surgery (ASCFS) and International Society of Craniofacial Surgery (ISCFS) are conducting a research program in a probe to increase awareness pertaining to CMF surgeries.
Moreover, rising geriatric population and healthcare expenditure are some other factors presumed to drive the demand for CMF surgeries over the forecast period. Incorporation of technologically advanced 3D printed implants used in cranial reconstructive surgery aimed at increasing adoption is further anticipated to provide this market with lucrative growth opportunities.
Craniomaxillofacial devices product segment encompasses Temporomandibular Joint (TMJ) replacement, CMF distraction, cranial flap fixation, CMF plate and screw fixation, bone graft substitutes, and thoracic fixation.
CMF plate and screw fixation led the product segment with the market share of over 70% in 2018. This dominance is attributed to its wide usage in various surgical procedures such as deformity correction, orthognathic surgery, tumor removal, and pediatric surgeries. The cranial flap fixation devices found applications in neurosurgery and ENT as well as plastic surgeries as they are used to open the scalp in craniotomy procedures and in facial plastic surgeries for correction of facial deformities.
Technological advancements such as an introduction of titanium cranial fixation system and increasing efficacy of the devices are the factors contributing to the growth of cranial flap fixation segment. Moreover, bio absorbable polymers-based implants are likely to gain popularity in near future.
TMJ replacement devices are expected to witness fastest CAGR over the forecast period due to increasing incidence of road accidents and sports injuries leading to cranial and facial fractures. TMJ devices are used in prosthetic jaw replacement surgery. It founds application in orthognathic and dental surgeries as well as plastic surgeries including fused joints, fractures, degenerated joints, abnormalities, and arthritic conditions.
These devices help reduce jaw pain, interference with eating and increases mouth opening capacity. TMJ replacement is the fastest growing segment, due to increasing number of cosmetic surgery such as chin augmentation and jaw replacement for improving the facial appearance.
Metallic implants led the overall material market owing to the advantages of the materials such as lower corrosiveness, ability to provide rigid support to the fractures, comparatively cheaper price than bioabsorbable counterparts, and higher market penetration than other materials. Metals are used in the CMF surgery because they are less corrosive in nature and physiologically support the fractures.
Titanium and its alloy are the most commonly used metals for CMF surgery due to advantage associated with it, such as light weight, inert metallic property, strength provided to implants, high tissue acceptance, and corrosion resistance. It is used in the mandibular reconstruction.
Bioabsorbable materials are expected to register lucrative growth over the forecast period, as usage of these implants nullifies the chances of a second surgery, required in case of metallic implants and easy assimilation in the body system. Technological advancement in the CMF surgery, for example, self-inforced technology and advantages associated with it such as biocompatible, easily handled, degradable property, and reliability are the factors expected to propel the market growth.
Furthermore, increasing government initiatives aimed at creating awareness pertaining to the use of CMF surgeries in the correction of deformities is also expected to widen the consumer base for the segment growth in the forthcoming years.
Neurosurgery and ENT held the largest revenue share as of 2018, owing to increasing incidence of trauma and spinal disorders requiring Cerebrospinal Fluid (CSF) management during surgery. Surgeons perform craniotomies to gain greater access to brain during neurosurgery.Craniotomies are done to treat trauma, infection in brains, skull fractures, aneurysm, epilepsy, Parkinson’s disease, pressure in brain after stroke or an injury, and to remove blood clots from head injury.
Moreover, adoption of deep brain stimulation procedures is one of the key contributing factors for this segment growth. In deep brain stimulation, the implants are used to cover the skull after inserting the electrode. Neurosurgical application of cranial implants consists of surgery of skull and otolaryngology procedures. These devices assist in treating neuro-oncology, neurovascular diseases, spinal disorders, dura mater repair, transnasal skull based surgery, deep brain stimulation, pelvic or cranial trauma, and CSF anagement. Medpor bioabsorbable implants are most commonly used for neurosurgery.
In addition, introduction of surgical navigation technology for ENT procedures is expected to fuel growth of the craniomaxillofacial devices market growth over the forecast period. Advantages associated with this technology, such as ease of use, 3D display, and real-time virtual anatomy updates are anticipated to boost the adoption in near future.
Plastic surgery is expected to witness the fastest CAGR owing to growing awareness and demand for aesthetic procedures and increasing expenditure on cosmetic surgeries especially in developed economies such as U.S. Additionally, craniomaxillofacial devices are used in Maxillofacial Oncologic and Reconstructive Surgery (MORS) are expected to gain popularity in the forthcoming years, which thereby contributes to the segment growth.
North America led with a market share of over 58% in terms of revenue in 2018, owing to increasing incidence of facial deformities and facial fractures due to increasing industrialization. Introduction of technologically advanced cranial implants, rising demand for minimally invasive surgeries, availability of sophisticated healthcare infrastructure, and high patient awareness levels are the factors attributed to the impressive growth.
U.S. accounted for the largest revenue share, owing to increasing demand for outpatient activities and prevalence of healthcare associated infections. In addition, rising burden from government authorities to implement safety guidelines is expected to propel the growth over the forecast period.
Presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and rising patient awareness are the key impact rendering drivers, accounting for lucrative growth of craniomaxillofacial industry in Asia Pacific.
The market is highly competitive in nature and dominated by a limited number of players. The most notable participants are DePuy Synthes (J&J), Stryker, Medtronic, and Zimmer-Biomet. These companies account for a significant revenue share in U.S. due to their extensive product offerings. DePuy Synthes continued introducing innovative new products that carry a smaller profile and provide good outcomes for patients resulting in capturing more revenue share.
Manufacturers are involved in the establishment of extensive distribution systems to increase geographical reach, collaborative strategies, and expansion of product portfolio. For instance, In March 2015, Stryker launched the next generation viable bone matrix at the American Academy of Orthopedic Surgeons, which is used for the bone regeneration procedures. This new product launch is implemented to capture the new market for the craniomaxillofacial division.
In addition, demand for low cost and effective products is expected to keep the competition at a high level. Many small medical device manufacturers are involved in the development of technologically advanced products with greater efficiency. For instance, in January 2017, OSSDSIGN received the U.S. Food and Drug Administration (FDA) approval for its OSSDSIGN Cranial implants. This fully customizable implant can help prevent infection. These benefits are expected to widen its usage over the forecast period.
Base year for estimation
Actual estimates/Historical data
2014 - 2017
2019 - 2026
Revenue in USD Million & CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America, MEA
Revenue forecast, company share, competitive landscape, growth factors and trends
U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, Singapore, Malaysia Brazil, Mexico, South Africa, Saudi Arabia
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global craniomaxillofacial devices market report on the basis of product, material, application, and region:
Product Outlook (Revenue, USD Million, 2014 - 2026)
Cranial Flap Fixation
Temporomandibular Joint Replacement
Bone Graft Substitute
MF Plate and Screw Fixation
Material Outlook (Revenue, USD Million, 2014 - 2026)
Application Outlook (Revenue, USD Million, 2014 - 2026)
Neurosurgery & ENT
Orthognathic and Dental Surgery
Regional Outlook (Revenue, USD Million, 2014 - 2026)
Middle East & Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.